Kat & chazzle -- thank you to whatvyou are both sa
Post# of 148707
The beauty of what I'm reading from your banter is --- either scenario, Leronlimab becomes part of the solution.
Even if it's a 3 drug combo for now, we know the R&D on dropping ART will continue or including even at least reducing the ART dosing & toxicity effects, due to Leronlimab
Either of your two scenarios -- LL is the cornerstone.
Outstanding & thx!!